BIO972 Israel. Science. Community.
About bio972
Don't Miss
- Teva Announces Sale of Pennsylvania Facility
- Byzantine Grape Seeds Discovered in the Negev
- Evogene to Build Research Facility in the United States
- MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week
- Evogene Incorporates Gene Optimization Program into Collaboration with Monsanto
- Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
- Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement
- Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue
- cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy
- Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa
